The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed Steven Davies as its new Chief Financial and Commercial Officer, strengthening its executive leadership team as the organisation begins delivery of its long-term 2030 Strategy.
Davies joins the regulator from Guy's and St Thomas' NHS Foundation Trust, where he currently serves as Chief Financial and Investment Officer. He brings with him 25 years of NHS finance and leadership experience, having begun his career on the NHS national finance graduate scheme in 2000.
His appointment comes at a crucial time for the MHRA as it seeks to modernise its operations, invest in new technologies and laboratory capabilities, and strengthen the UK's position as a global centre for life sciences innovation.
Davies has extensive experience across the healthcare sector, including previous roles at Moorfields Eye Hospital NHS Foundation Trust, where he served as Chief Financial Officer and Deputy Chief Executive.
In his new position, he will oversee the MHRA's financial management, commercial strategy and major investment programmes, ensuring the agency has the financial foundations necessary to deliver its strategic objectives over the next five years.
Supporting the MHRA's Strategic Vision
The MHRA recently unveiled its 2030 Strategy, setting out plans to enhance regulation, support innovation and improve outcomes for patients while maintaining the highest standards of safety and effectiveness.
As Chief Financial and Commercial Officer, Davies will play a key role in shaping the agency's commercial model and overseeing investment in critical infrastructure, including digital technology and laboratory facilities.
Lawrence Tallon, MHRA Chief Executive, said:
“I’m delighted to welcome Steve to the MHRA. His deep financial and commercial expertise, and dynamic leadership style, will be invaluable as we set out to deliver our ambitious 2030 Strategy, with its associated revenue streams and capital investments in tech and labs. I look forward to working with Steve to optimise the funding model for innovators using MHRA services, and to design a regulatory framework that encourages inward investment to the UK life sciences industry.”
Davies said he was looking forward to helping the regulator deliver on its ambitions and support innovation across the health and life sciences sectors.
Steven Davies, incoming MHRA Chief Finance and Commercial Officer, said:
“I’m hugely excited to be joining the MHRA as Chief Finance and Commercial Officer at such an important time. The Agency’s ambitious new strategy will bring real benefits for patients, innovators and the wider UK. Over the coming years, I look forward to working with colleagues across the Agency and partners across the health and life sciences system, to make sure the MHRA has the strong financial and commercial foundations it needs to deliver it.”

The appointment reflects the MHRA's continued focus on strengthening its leadership capabilities as it seeks to support innovation, attract investment and maintain the UK's reputation as a leading destination for life sciences research, development and regulation.
Image credit: iStock
